Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1

The elimination of viruses and tumors by natural killer cells is mediated by specific natural killer cell receptors. To study the in vivo function of a principal activating natural killer cell receptor, NCR1 (NKp46 in humans), we replaced the gene encoding this receptor (Ncr1) with a green fluorescent protein reporter cassette. There was enhanced spread of certain tumors in 129/Sv but not C57BL/6 Ncr1gfp/gfp mice, and influenza virus infection was lethal in both 129/Sv and C57BL/6 Ncr1gfp/gfp mice. We noted accumulation of natural killer cells at the site of influenza infection by tracking the green fluorescent protein. Our results demonstrate a critical function for Ncr1 in the in vivo eradication of influenza virus.

[1]  Angel Porgador,et al.  Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells , 2001, Nature.

[2]  K. Kärre.  NK Cells, MHC Class I Molecules and the Missing Self , 2002, Scandinavian journal of immunology.

[3]  L. Moretta,et al.  IL‐21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig‐like receptors , 2003, European journal of immunology.

[4]  J. Williams,et al.  Natural killer cell receptors in cattle: a bovine killer cell immunoglobulin‐like receptor multigene family contains members with divergent signaling motifs , 2003, European journal of immunology.

[5]  S. Anderson,et al.  Aberrant DAP12 Signaling in the 129 Strain of Mice: Implications for the Analysis of Gene-Targeted Mice1 , 2002, The Journal of Immunology.

[6]  R. Biassoni,et al.  Human Natural Killer cell receptors: insights into their molecular function and structure , 2003, Journal of cellular and molecular medicine.

[7]  A. Moretta,et al.  Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines. , 2000, Human immunology.

[8]  J. Orange.  Human natural killer cell deficiencies and susceptibility to infection. , 2002, Microbes and infection.

[9]  D. Fearon,et al.  A subpopulation of B220+ cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors , 1996, The Journal of experimental medicine.

[10]  L. Moretta,et al.  The impaired NK cell cytolytic function in viremic HIV‐1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44) , 2003, European journal of immunology.

[11]  R. Biassoni,et al.  The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity , 1999, European journal of immunology.

[12]  R. Biassoni,et al.  Identification, molecular cloning and functional characterization of NKp46 and NKp30 natural cytotoxicity receptors in Macaca fascicularis NK cells , 2001, European journal of immunology.

[13]  W. Yokoyama,et al.  The dynamic life of natural killer cells. , 2004, Annual review of immunology.

[14]  C. Biron,et al.  Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.

[15]  R. Biassoni,et al.  Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. , 2001, Annual review of immunology.

[16]  L. Moretta,et al.  NK cell‐mediated lysis of autologous antigen‐presenting cells is triggered by the engagement of the phosphatidylinositol 3‐kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46 , 2001, European journal of immunology.

[17]  A. Moretta,et al.  Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines , 2000, Journal of Neuroimmunology.

[18]  M. Korc,et al.  Membrane-Associated Heparan Sulfate Proteoglycans Are Involved in the Recognition of Cellular Targets by NKp30 and NKp461 , 2004, The Journal of Immunology.

[19]  L. Moretta,et al.  Unravelling natural killer cell function: triggering and inhibitory human NK receptors , 2004, The EMBO journal.

[20]  R. Biassoni,et al.  Identification of the rat homologue of the human NKp46 triggering receptor. , 1999, Immunology letters.

[21]  Eric O Long.  Tumor cell recognition by natural killer cells. , 2002, Seminars in cancer biology.

[22]  J L Sullivan,et al.  Severe herpesvirus infections in an adolescent without natural killer cells. , 1989, The New England journal of medicine.

[23]  O. Mandelboim,et al.  The NKp46 Receptor Contributes to NK Cell Lysis of Mononuclear Phagocytes Infected with an Intracellular Bacterium1 , 2002, The Journal of Immunology.

[24]  Timothy K Starr,et al.  Positive and negative selection of T cells. , 2003, Annual review of immunology.

[25]  L. Lanier,et al.  Cutting Edge: The Mouse NK Cell-Associated Antigen Recognized by DX5 Moncoclonal Antibody is CD49b (α2 Integrin, Very Late Antigen-2)1 , 2001, The Journal of Immunology.

[26]  J. Hanna,et al.  The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients. , 2004, Blood.

[27]  R. Biassoni,et al.  NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells , 1999, European journal of immunology.

[28]  J Stein-Streilein,et al.  In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection. , 1986, Journal of immunology.

[29]  Angel Porgador,et al.  Recognition of viral hemagglutinins by NKp44 but not by NKp30 , 2001, European journal of immunology.

[30]  A. Porgador,et al.  Non-replicating mucosal and systemic vaccines: quantitative and qualitative differences in the Ag-specific CD8(+) T cell population in different tissues. , 2004, Vaccine.

[31]  Angel Porgador,et al.  The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. , 2004, Blood.

[32]  N. Shastri,et al.  Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages , 2000, Nature Immunology.

[33]  É. Vivier,et al.  Loss or mismatch of MHC class I is sufficient to trigger NK cell‐mediated rejection of resting lymphocytes in vivo – role of KARAP/DAP12‐dependent and ‐independent pathways , 2004, European journal of immunology.

[34]  R. Biassoni,et al.  Molecular Cloning of NKp46: A Novel Member of the Immunoglobulin Superfamily Involved in Triggering of Natural Cytotoxicity , 1998, The Journal of experimental medicine.

[35]  C. Falk,et al.  Renal cell carcinoma‐infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes , 2003, International journal of cancer.

[36]  D. Olive,et al.  Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. , 2002, Blood.

[37]  O. Mandelboim,et al.  Murine B-cell leukemia lymphoma (BCL1) cells as a target for NK cell-mediated immunotherapy , 2004, Bone Marrow Transplantation.

[38]  J. Ortaldo,et al.  Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases , 2002, Nature Immunology.

[39]  J. Roder,et al.  Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[40]  H. Young,et al.  Role of Natural Killer Cells in Innate Protection against Lethal Ebola Virus Infection , 2004, The Journal of experimental medicine.